Marijuana Stocks Price: MORE Act lifts prices from lows, financials still weigh

Cannabis stocks have cut short a losing streak amid hopes for better legal standing.
Financials of companies may limit further gains.
Aurora remains under pressure amid a highly dilutive deal.

Marijuana stocks have gone higher on Tuesday as the US House Judiciary Committee announced plans to advance a bill that would legalize cannabis on the federal level. Consumption of cannabis is legal to various degrees, only in multiple states.

Lawmakers led by Jerrold Nadler, the committee's Chairman, are promoting the Marijuana Opportunity Reinvestment and Expungement Act (More Act) that would help individuals suffering from life-damaging convictions the ability to access housing and vote. For weed stocks, having access to a full American market is a boon. The news sent shares higher with Cronus (CRON) jumping by over 9% following the news.

While House Democrats are moving forward with the More Act on Wednesday, it is unclear if Republicans will go along. Mitch McConnell, the majority leader, has met with executives of marijuana-related firms but has been a life-long opponent of legalization.

Marijuana Stocks Today

Nevertheless, weed equities are still struggling with sky-high expectations after the opening of the Canadian market have met the reality of making money. Aurora Cannabis is standing out with a highly dilutive offer on its convertible bonds. Despite the recovery, Aurora's stock price is down around a third in the past month.

The boom in the number of cannabis farms and their pricing may lead to bankruptcies down the road – even if the American market were to open fully.

Tilary, a company whose stocks have surged around Canada's decision, has missed Wall Street's expectations with substantial losses. The firm reported gross sales of $51.1 million but losses of $23.3 million. Its stock price will likely remain in the limelight on Wednesday.

Wednesday's trading will likely be marked by legislative efforts and speculation about the potential profitability of

See Marijuana Stocks Not Getting Investors High Ahead of Earnings

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.